CMV Specific CD4 T Cells and Viremia After Stem Cell Transplantation
Author Information
Author(s): Widmann Thomas, Sester Urban, Gärtner Barbara C., Schubert Jörg, Pfreundschuh Michael, Köhler Hans, Sester Martina
Primary Institution: University clinics of the Saarland, Homburg, Germany
Hypothesis
The dynamics of CMV-specific T cells correlate with CMV viremia in allogeneic stem cell transplant recipients.
Conclusion
CMV-specific CD4 T cell levels inversely correlate with reactivation episodes and may help guide antiviral therapy after stem cell transplantation.
Supporting Evidence
- 87.5% of patients reconstituted CMV specific T-cell immunity after transplantation.
- 29 episodes of CMV viremia were observed in 21 patients.
- CMV-specific CD4 T cell levels were significantly lower during viremia compared to non-viremic patients.
- Therapeutic dosages of cyclosporine A and corticosteroids reduced CMV-specific T-cell functions.
Takeaway
This study found that the number of special immune cells that fight a virus called CMV changes a lot when the virus is active, which can help doctors decide when to give medicine to fight the virus.
Methodology
The study analyzed CMV-specific CD4 and CD8 T cells in 40 allogeneic transplant recipients using intracellular cytokine staining and MHC class I multimers.
Potential Biases
Potential bias due to the observational nature of the study and the specific immunosuppressive treatments used.
Limitations
The study was limited to a specific patient population and may not generalize to all transplant recipients.
Participant Demographics
Mean age 44.9 years, 27 males and 13 females.
Statistical Information
P-Value
p=0.02
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website